Imegen-SCAs

Detection of expansions associated with spinocerebellar and other cerebellar ataxias (SCA1, SCA2, SCA3, SCA6, SCA7, SCA12, SCA17 and DRPLA) related to neurodegenerative diseases

12 x 8 rxn

Fragment analysis

IMG-152

  • Semi-quantitative analysis
  • Amplification range of 100-500 bp.
  • Includes TP-PCR systems to detect described expansions resulting in amplicon sizes> 500 bp.
  • It includes a positive control at the optimal amplification concentration, in which normal alleles are present for all the analyzes carried out with the kit, to demonstrate the functionality of the amplification reactions prepared.
  • Designed and validated with the same PCR program as related products for the analysis of expansions implicated in other neurodegenerative diseases, so they can be analyzed together.
  • It complies with the quality requirements specified by ISO 13845 and ISO 14001 regarding the materials used in its manufacturing process.
  • For in vitrodiagnostic use.

Imegen-SCAs allows the analysis of CAG or CAG / CAA triplet expansions associated with cerebellar ataxias using conventional PCR and capillary electrophoresis. In addition, the kit offers a TP-PCR (triplet repeat primed PCR) system to detect expansions of SCA2 and SCA7 not detectable with conventional PCR.

  • Amount of DNA required: 50 ng for each amplification system
  • Sample type: Peripheral blood (Germinal)
  • Number of reactions per sample: 10 (8 from PCR and 2 from TP-PCR)
  • Number of targets: 8 (SCA1, SCA2, SCA3, SCA6, SCA7, SCA12, SCA17 and DRPLA)
  • Manual work time: 45 minutes
  • Duration of the PCR / TP-PCR program: 2 h 30 min
  • Compatible thermal cyclers: Any conventional thermal cycler
  • Sequencing with polymers compatible with the 6-Carboxyfluorescein (6-FAM) label.

Imegen-SCAs

Fill in the form to request this kit.

Call us at +34 963 212 340

Or write to us at info@healthincode.com